glp-1 agonist drug interactions Trends in the Development of Receptor Agonists Peptidyl and Non-Peptidyl Oral Glucagon-Like

Clinical reviews have shown that this transmucosal route successfully bypasses the destructive enzymes of the GI tract and the liver's first-pass metabolism, resulting in a rapid and statistically significant increase in blood GSH concentrations

From a statistics standpoint, about 50% of adults (18) in the US have insulin resistance

These changes are gradual

Furthermore, this optimal treatment significantly boosted the activity of key antioxidant enzymes, SOD and AP, and increased the concentrations of essential pigments (chlorophyll a, b, and carotenoids) and macronutrients (phosphorus, magnesium, potassium, and nitrogen)

Ajdic D et al

PMID 23539619